These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30651293)

  • 21. Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status.
    Thasni KA; Rojini G; Rakesh SN; Ratheeshkumar T; Babu MS; Srinivas G; Banerji A; Srinivas P
    Eur J Pharmacol; 2008 Jul; 588(2-3):158-64. PubMed ID: 18514188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of folate receptor alpha in ovarian epithelial tumors].
    Shen DH; Xie JL; Zhang YL; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):747-51. PubMed ID: 21215165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-181 Functions as an Antioncogene and Mediates NF-κB Pathway by Targeting RTKN2 in Ovarian Cancers.
    Lin Z; Li D; Cheng W; Wu J; Wang K; Hu Y
    Reprod Sci; 2019 Aug; 26(8):1071-1081. PubMed ID: 30309296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome in serous ovarian cancer is not associated with LATS expression.
    Montavon C; Stricker GR; Schoetzau A; Heinzelmann-Schwarz V; Jacob F; Fedier A
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2737-2749. PubMed ID: 31586262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell proliferation activity unrelated to COX-2 expression in ovarian tumors.
    Yoshida A; Sarian LO; Andrade LA; Pignataro F; Pinto GA; Derchain SF
    Int J Gynecol Cancer; 2007; 17(3):607-14. PubMed ID: 17504375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance].
    Zhang LL; Shao SL; Wu Y
    Chin J Cancer; 2010 Jan; 29(1):25-9. PubMed ID: 20038306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
    Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
    Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma.
    Chen L; Zhai Y; Wang Y; Fearon ER; Núñez G; Inohara N; Cho KR
    Cancer Res; 2021 Jun; 81(12):3309-3318. PubMed ID: 33863776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
    Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
    Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calpain system protein expression and activity in ovarian cancer.
    Zhang S; Deen S; Storr SJ; Chondrou PS; Nicholls H; Yao A; Rungsakaolert P; Martin SG
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):345-361. PubMed ID: 30448882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF18 as a potential biomarker in serous and mucinous ovarian tumors.
    El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA
    Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprevention of spontaneous ovarian cancer in the domestic hen.
    Mocka EH; Stern RA; Fletcher OJ; Anderson KE; Petitte JN; Mozdziak PE
    Poult Sci; 2017 Jun; 96(6):1901-1909. PubMed ID: 27915270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 16 expression changes in association with ovarian malignant transformation.
    Yellapa A; Bitterman P; Sharma S; Guirguis AS; Bahr JM; Basu S; Abramowicz JS; Barua A
    Am J Obstet Gynecol; 2014 Mar; 210(3):272.e1-10. PubMed ID: 24380743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 36. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of estrogenic compounds, 4-nonylphenol and genistein, on 7,12-dimethylbenz[a]anthracene-induced ovarian carcinogenesis in rats.
    Tanaka T; Kohno H; Tanino M; Yanaida Y
    Ecotoxicol Environ Saf; 2002 May; 52(1):38-45. PubMed ID: 12051806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genistein induces apoptosis by the inactivation of the IGF-1R/p-Akt signaling pathway in MCF-7 human breast cancer cells.
    Chen J; Duan Y; Zhang X; Ye Y; Ge B; Chen J
    Food Funct; 2015 Mar; 6(3):995-1000. PubMed ID: 25675448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogenesis in laying hen model of spontaneous ovarian cancer.
    Yellapa A; Bahr JM; Bitterman P; Abramowicz JS; Edassery SL; Penumatsa K; Basu S; Rotmensch J; Barua A
    Int J Gynecol Cancer; 2012 Feb; 22(2):199-207. PubMed ID: 22274315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer.
    Barua A; Bitterman P; Abramowicz JS; Dirks AL; Bahr JM; Hales DB; Bradaric MJ; Edassery SL; Rotmensch J; Luborsky JL
    Int J Gynecol Cancer; 2009 May; 19(4):531-9. PubMed ID: 19509547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.